Investigations & Compliance
Brian has conducted hundreds of internal investigations into alleged misconduct around the world, and has represented corporations, boards, and individuals before the DOJ, SEC, the UK Serious Fraud Office, and other U.S. and international regulators. As General Counsel of GSK China, he led the company’s response to a landmark criminal bribery case, obtaining declinations from U.S. and UK authorities in parallel proceedings.
Not every internal investigation should become a major undertaking. Many begin with a single allegation involving one employee, business unit, or country. The company’s immediate objective is often straightforward: determine whether the allegation has merit, preserve relevant evidence, understand the potential exposure, and decide what should happen next.
A properly scoped investigation can often answer those questions at an early stage without unnecessary disruption to the business. If the facts warrant a broader inquiry, one can always follow.
That approach allows companies to respond appropriately while remaining mindful of cost, business continuity, and the practical realities facing in-house legal and compliance teams.
Internal Investigations
Privileged, discreet investigations designed to withstand regulatory, auditor, and market scrutiny, with efficient scoping and flat-fee billing.
Government Investigations
Representation before the DOJ, SEC, and other U.S. and foreign authorities, from first inquiry through resolution.
Compliance Due Diligence
Unlike deal counsel, Brian has no stake in whether a transaction closes, which allows him to take an objective and independent view of a target’s or counterparty’s suitability, drawn from having conducted diligence on transactions worth over $20B in total.
Cross-Border Counseling & Risk Advisory
Guidance on enterprise risks arising from global operations, including supply-chain integrity, export controls, economic sanctions, corruption, and third-party due diligence.
Crisis Prevention & Management
Strategic counsel to leadership on sensitive, fast-moving matters carrying legal, commercial, and reputational consequences.
Selected Engagements
Obtained declinations from the DOJ, SEC and UK Serious Fraud Office on behalf of a global publisher in investigations into alleged bribery in Brazil, India, South Korea and China.
Obtained an FCPA declination from the DOJ on behalf of a U.S.-listed medical device manufacturer with respect to alleged conduct by employees and distributors in India.
Designed and implemented a global compliance program for a leading international luxury fashion group and conducted multiple compliance reviews.
Led a global pharmaceutical company's on-the-ground response to a landmark criminal bribery prosecution in China, obtaining declinations from U.S. and UK authorities in parallel proceedings.
Performed over a dozen risk assessments for Fortune 500 clients with respect to commercial operations in high-risk jurisdictions.
Representing a U.S.-listed biotechnology company in a criminal investigation by the DOJ into alleged manipulation of clinical trial data.
Representing a U.S.-listed technology company in SEC and DOJ investigations into alleged securities fraud and data protection breaches.
Representing a U.S. fintech company in a criminal investigation by the DOJ relating to alleged anti-money-laundering and Bank Secrecy Act violations.
Represented a European automotive company in investigations by BIS and CBP relating to potential violations of the Uyghur Forced Labor Prevention Act.
Conducted compliance due diligence and risk assessments for venture capital and private equity firms on investments totaling over $10 billion.
20+ Years Advising Fortune 500 Companies and Boards
Hundreds of Internal Investigations Worldwide
Declinations Obtained from the DOJ, SEC and SFO
Chambers-Ranked
Admitted in New York and Hong Kong